A highly sensitive HPLC method for the simultaneous determination of acetylsalicylic, salicylic and salicyluric acids in biologic fluids: Pharmacokinetic, metabolic and monitoring implications

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 18, Issue 8, 1996, Pages 527-532

  Krivosikova Z ^a   Spustova V ^a   Dzurik R ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

Acetylsalicylic acid; Aspirin; HPLC; Pharmacokinetics; Salicylic acid; Salicyluric acid

Indexed keywords

ACETYLSALICYLIC ACID; DRUG METABOLITE; SALICYLIC ACID; SALICYLURIC ACID;

ADULT; ARTICLE; DRUG ABSORPTION; DRUG CONJUGATION; DRUG DETERMINATION; DRUG ELIMINATION; DRUG METABOLISM; DRUG TISSUE LEVEL; FEMALE; GASTROINTESTINAL TRACT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; VOLUNTEER;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HIPPURATES; HUMANS; MALE; SALICYLIC ACID; SALICYLIC ACIDS;

EID: 0030445355     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Weissman, G. Aspirin. Sci Am 1991, 264: 58-64.
2. Hoffman, W., Forster, W. Zeiejahrstudie an den Hertzinfarkt-Patienten des Bezirkes Cottbus mit 30, 60 und 1000 mg Acetylsalicylsaure je Tag - Einfluss auf Reinfarkt-Morbiditat und Letalitat. Z Klin Med 1987, 42: 2097-101.
3. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. New Engl J Med 1991, 325: 1261-6.
4. Bakar, S.K., Niazi, S. Stability of aspirin in different media. J Pharm Sci 1983, 72: 1024-6.
5. Buskin, J.N., Upton, R.A., Williams, R.L. Improved liquid-chromatography of aspirin, salicylate and salicyluric acid in plasma, with a modification for determining aspirin metabolites in urine. Clin Chem 1982, 28 (5): 1200-3.
6. Mays, D.C., Sharp, D.E., Beach, C.A. et al. Improved method for determination of aspirin and its metabolites in biological fluids by high-performance liquid chromatography: Applications to human and animal studies. J Chromatogr 1984, 311: 301-9.
7. Yamada, K., Asano, O., Yoshimira, T., Katayama, K. Highly sensitive gas chromatographic-mass spectrometric method for the determination of platelet-activating factor in human blood. J Chromatogr 1988, 433: 243-7.
8. Siebert, D.M., Bochner, F. Determination of plasma aspirin and salicylic acid concentrations after low doses by high-performance liquid chromatography with post-column hydrolysis and fluorescence detection. J Chromatogr 1987, 420: 425-31.
9. Lo, L.Y., Bye, A. Specific and sensitive method for the determination of aspirin and salicylic acid in plasma using reversed-phase high-performance liquid chromatography. J Chromatogr 1980, 181: 473-7.
10. Reidl, U. Determination of acetylsalicylic acid and metabolites in biological fluids by high-performance liquid chromatography. J Chromatogr 1983, 272: 325-31.
11. Dubovská, D., Piotrovskij, V.K., Gajdos, M. et al. Pharmacokinetics of acetylsalicylic acid and its metabolites at low doses: A compartmental modeling. Meth Find Exp Clin Pharmacol 1995, 17 (1): 67-77.
12. Voss, R., Geissler, B.S., Tillmanns, H. In vitro and ex vivo effects of aspirin in patients on a low-dose aspirin therapy. Thromb Res 1993, 72: 49-57.